FI963598L - Immunoterapeutiskt förfarande för behandling av kancersjukdomar genom givande av gammaglobuliner - Google Patents

Immunoterapeutiskt förfarande för behandling av kancersjukdomar genom givande av gammaglobuliner Download PDF

Info

Publication number: FI963598L
Authority: FI; Finland
Prior art keywords: treating cancer; cancer diseases; gamma globulins; immunotherapeutic method; administering gamma
Prior art date: 1994-03-14

Application number

FI963598A

Other languages

English (en)

Finnish (fi)

Other versions

FI114011B (sv

FI963598A0 (sv

Inventor

Yehuda Shoenfeld

Pnina Fishman

Original Assignee

Arp Biomed Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-03-14

Filing date

1996-09-12

Publication date

1996-09-12

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26907064&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI963598(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1996-09-12 Application filed by Arp Biomed Inc filed Critical Arp Biomed Inc

1996-09-12 Publication of FI963598L publication Critical patent/FI963598L/sv

1996-09-12 Publication of FI963598A0 publication Critical patent/FI963598A0/sv

2004-07-30 Application granted granted Critical

2004-07-30 Publication of FI114011B publication Critical patent/FI114011B/sv

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/54—F(ab')2

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biochemistry (AREA)
Immunology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Genetics & Genomics (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Oncology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

FI963598A 1994-03-14 1996-09-12 Användning av immunoglobulin som är avsedd för intrarenös användning för framställning av en farmaceutisk komposition för behandling av cancersjukdomar FI114011B (sv)

Applications Claiming Priority (6)

Application Number	Priority Date	Filing Date	Title
US21236194A	1994-03-14	1994-03-14
US21236194		1994-03-14
US08/340,094 US5562902A (en)	1994-03-14	1994-11-15	Immunotherapeutic method of treating cancerous diseases by administration of intravenous immunoglobulin
US34009494		1994-11-15
PCT/US1995/002910 WO1995024927A1 (en)	1994-03-14	1995-03-09	Immunotherapeutic method of treating cancerous diseases by administration of gamma globulins
US9502910		1995-03-09

Publications (3)

Publication Number	Publication Date
FI963598L true FI963598L (sv)	1996-09-12
FI963598A0 FI963598A0 (sv)	1996-09-12
FI114011B FI114011B (sv)	2004-07-30

Family

ID=26907064

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FI963598A FI114011B (sv)	1994-03-14	1996-09-12	Användning av immunoglobulin som är avsedd för intrarenös användning för framställning av en farmaceutisk komposition för behandling av cancersjukdomar

Country Status (20)

Country	Link
US (2)	US5562902A (sv)
EP (1)	EP0750514B1 (sv)
JP (2)	JP4004062B2 (sv)
KR (1)	KR100352583B1 (sv)
CN (1)	CN1089007C (sv)
AT (1)	ATE198711T1 (sv)
AU (1)	AU700751B2 (sv)
BR (1)	BR9507067A (sv)
CA (1)	CA2184269A1 (sv)
DE (1)	DE69519924T2 (sv)
DK (1)	DK0750514T3 (sv)
ES (1)	ES2155519T3 (sv)
FI (1)	FI114011B (sv)
GR (1)	GR3035758T3 (sv)
HK (1)	HK1014493A1 (sv)
IL (1)	IL112963A (sv)
NZ (1)	NZ282659A (sv)
PT (1)	PT750514E (sv)
TW (1)	TW418091B (sv)
WO (1)	WO1995024927A1 (sv)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20070166313A1 (en) *	1994-03-14	2007-07-19	Yehuda Shoenfeld	Administration of gamma globulins to treat cancer
US20080050390A1 (en) *	1994-03-14	2008-02-28	Yehuda Shoenfeld	Administration of gamma globulins to treat metastatic melanoma
CA2331738A1 (en)	1998-05-07	1999-11-11	Research Corporation Technologies, Inc.	Oral administration of immunoglobulins for treating autoimmune hearing loss
TWI248819B (en) *	1999-09-27	2006-02-11	Arp Biomed Ltd	Pharmaceutical composition containing IVIG for use in treating lymphoma
AU4079001A (en) *	2000-03-10	2001-09-17	Medinnova As	Composition for the treatment of heart failure
AT410637B (de) *	2001-06-01	2003-06-25	Igeneon Krebs Immuntherapie	Verwendung von polyklonalen immunglobulinen
US20050106136A1 (en)	2002-02-15	2005-05-19	Richard Brunner	7s immunoglobulin for treatment of choroidal neovascularisation
US20080031903A1 (en) *	2006-07-27	2008-02-07	Andrea Gambotto	Method of treating ocular infections
US20090053217A1 (en) *	2007-05-07	2009-02-26	Miri Blank	Human anti-VEGF polyclonal antibodies and uses thereof
US20110311557A1 (en) *	2009-02-11	2011-12-22	Martin Heath Bluth	Reciprocal serum/plasma exchange for the treatment of cancer
CN114129722B (zh) *	2020-09-04	2024-04-05	中国医学科学院输血研究所	注射用人免疫球蛋白在制备预防或治疗辐照损伤的药物中的用途
CN114392351B (zh) *	2021-07-13	2024-04-05	中国医学科学院放射医学研究所	毛螺菌科细菌与注射用人免疫球蛋白的联合用药物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4699783A (en) *	1983-03-11	1987-10-13	Terman David S	Products and methods for treatment of cancer
US4834975A (en) *	1984-05-25	1989-05-30	Genetics Corporation	Human monoclonal antibodies to serotypic lipopolysaccharide determinants on gram-negative bacteria and their production
US4699784A (en) *	1986-02-25	1987-10-13	Center For Molecular Medicine & Immunology	Tumoricidal methotrexate-antibody conjugate
TWI248819B (en) *	1999-09-27	2006-02-11	Arp Biomed Ltd	Pharmaceutical composition containing IVIG for use in treating lymphoma

1994
- 1994-11-15 US US08/340,094 patent/US5562902A/en not_active Expired - Lifetime
1995
- 1995-03-09 AT AT95912808T patent/ATE198711T1/de not_active IP Right Cessation
- 1995-03-09 ES ES95912808T patent/ES2155519T3/es not_active Expired - Lifetime
- 1995-03-09 DE DE69519924T patent/DE69519924T2/de not_active Expired - Lifetime
- 1995-03-09 JP JP52408195A patent/JP4004062B2/ja not_active Expired - Fee Related
- 1995-03-09 KR KR1019960705054A patent/KR100352583B1/ko not_active Expired - Fee Related
- 1995-03-09 CN CN95192080A patent/CN1089007C/zh not_active Expired - Fee Related
- 1995-03-09 PT PT95912808T patent/PT750514E/pt unknown
- 1995-03-09 EP EP95912808A patent/EP0750514B1/en not_active Expired - Lifetime
- 1995-03-09 WO PCT/US1995/002910 patent/WO1995024927A1/en active IP Right Grant
- 1995-03-09 CA CA002184269A patent/CA2184269A1/en not_active Abandoned
- 1995-03-09 AU AU19848/95A patent/AU700751B2/en not_active Ceased
- 1995-03-09 NZ NZ282659A patent/NZ282659A/en not_active IP Right Cessation
- 1995-03-09 DK DK95912808T patent/DK0750514T3/da active
- 1995-03-09 BR BR9507067A patent/BR9507067A/pt not_active Application Discontinuation
- 1995-03-12 IL IL11296395A patent/IL112963A/xx not_active IP Right Cessation
- 1995-03-13 TW TW084102356A patent/TW418091B/zh not_active IP Right Cessation
- 1995-06-07 US US08/487,803 patent/US5965130A/en not_active Expired - Fee Related
1996
- 1996-09-12 FI FI963598A patent/FI114011B/sv not_active IP Right Cessation
1998
- 1998-12-22 HK HK98114792A patent/HK1014493A1/xx not_active IP Right Cessation
2001
- 2001-04-17 GR GR20010400610T patent/GR3035758T3/el not_active IP Right Cessation
2007
- 2007-02-08 JP JP2007029855A patent/JP2007119493A/ja active Pending

Also Published As

Publication number	Publication date
AU1984895A (en)	1995-10-03
CA2184269A1 (en)	1995-09-21
BR9507067A (pt)	1997-09-30
CN1089007C (zh)	2002-08-14
JP4004062B2 (ja)	2007-11-07
DE69519924D1 (de)	2001-02-22
JPH09512791A (ja)	1997-12-22
FI114011B (sv)	2004-07-30
DE69519924T2 (de)	2001-08-23
CN1148343A (zh)	1997-04-23
EP0750514B1 (en)	2001-01-17
ATE198711T1 (de)	2001-02-15
US5965130A (en)	1999-10-12
NZ282659A (en)	1998-06-26
IL112963A (en)	2000-02-17
IL112963A0 (en)	1995-06-29
ES2155519T3 (es)	2001-05-16
JP2007119493A (ja)	2007-05-17
KR100352583B1 (ko)	2002-12-26
TW418091B (en)	2001-01-11
US5562902A (en)	1996-10-08
FI963598A0 (sv)	1996-09-12
PT750514E (pt)	2001-06-29
HK1014493A1 (en)	1999-09-30
WO1995024927A1 (en)	1995-09-21
GR3035758T3 (en)	2001-07-31
EP0750514A1 (en)	1997-01-02
DK0750514T3 (da)	2001-05-21
AU700751B2 (en)	1999-01-14

Publication	Publication Date	Title
FI943625A0 (sv)	1994-08-04	Förfaranden för behandling av inflammatoriska hudsjukdomar
FI971568L (sv)	1997-06-12	Förfarande för behandling av resistenta tumörer
IL114013A (en)	1999-12-31	Radiation source wire for radiation treatment of diseases
NO971015D0 (no)	1997-03-05	Forbindelser og metoder for behandling av cancer
ATE192157T1 (de)	2000-05-15	Therapeutisch verwendbare spiro-azabicyclische verbindungen
FI951596L (sv)	1995-04-04	Förfarande för erhållande av 10-desacetylbakkatin III
BR9610404A (pt)	1999-07-06	Anticorpos anti-cd4 recombinantes para terapia humana
FI955798L (sv)	1996-02-01	Terapeutiska antikroppfrangmenter
BR9206313A (pt)	1995-04-11	Anticorpos recombinantes para terapia humana.
DE69529857D1 (de)	2003-04-17	Strahlentherapie-System
FI960095L (sv)	1996-01-09	Förfarande för syntetisering av azetidinoner
FI970102L (sv)	1997-01-10	Förfarande för syntetisering av substituerade sulfoxider
DE3484520D1 (de)	1991-06-06	Monoklonale antikoerper gegen menschlichen dickdarmkrebs und verfahren.
NO970040D0 (no)	1997-01-06	Terapeutiske forbindelser
DK64592D0 (da)	1992-05-14	Peptider til terapeutisk behandling
NO985066D0 (no)	1998-10-30	Terapeutisk behandling for VEGF-relaterte sykdommer
FI963598L (sv)	1996-09-12	Immunoterapeutiskt förfarande för behandling av kancersjukdomar genom givande av gammaglobuliner
FI953899A (sv)	1995-08-18	Substituerade azonderivat för behandling av sjukdomar förorsakade av Helicobacter
FI960658L (sv)	1996-02-14	Nya bis-naftalimider för behandling av cancer
IL103205A0 (en)	1993-02-21	Compounds for treating leukotriene-related diseases
BR9304004A (pt)	1994-06-07	Método de tratamento de arrozal
FI944236L (sv)	1994-11-11	Förfarande för behandling av migrän
FI945877L (sv)	1995-06-16	Förfarande för att producera protein C
EE03437B1 (et)	2001-06-15	Benseenamiidid neurodegeneratiivsete haiguste ravimiseks
MD106B1 (ro)	1994-12-31	Metoda de tratament a cancerului mamar

Legal Events

Date	Code	Title	Description
1998-01-02	GB	Transfer or assigment of application	Owner name: ARP BIOMED LTD.
2011-11-25	MM	Patent lapsed